Version history

{
  "session_id": "sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-005103",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "synthesize",
  "content": "\n\n{\"ranked_hypotheses\":[{\"rank\":1,\"title\":\"TREM2-Dependent Microglial Phagocytosis and Lipid Processing\",\"mechanism\":\"TREM2 on microglia recognizes oxidized phospholipid epitopes on damaged cells, triggering phagocytosis and lysosomal degradation of OxPC-laden debris.\",\"target_gene\":\"TREM2\",\"confidence_score\":0.75,\"novelty_score\":0.55,\"feasibility_score\":0.8,\"impact_score\":0.85,\"composite_score\":0.74,\"testable_prediction\":\"Trem2-deficient mice crossed to cuprizone or MOG-EM model will show accumulation of OxPC deposits and worsened demyelination compared to controls.\",\"skeptic_concern\":\"Direct TREM2-OxPC binding affinity needs biochemical validation; alternative receptors like CD36 may compensate in knockout models.\"},{\"rank\":2,\"title\":\"ApoE-Mediated Lipid Sequestration and Efflux\",\"mechanism\":\"Microglial ApoE binds toxic OxPC species via its amphipathic helix domain, forming HDL-like particles that are exported via ABCA1/ABCG1 transporters.\",\"target_gene\":\"APOE\",\"confidence_score\":0.7,\"novelty_score\":0.65,\"feasibility_score\":0.55,\"impact_score\":0.75,\"composite_score\":0.68,\"testable_prediction\":\"Conditional Apoe deletion in microglia (Cx3cr1-CreERT2) will cause OxPC accumulation in active MS lesions and accelerated neuroaxonal loss.\",\"skeptic_concern\":\"The hypothesis lacks a mechanism for directional transcellular lipid transfer—neurons/oligodendrocytes have insufficient ABCA1 to initiate export to microglia.\"},{\"rank\":3,\"title\":\"MerTK-Mediated Apoptotic Cell Clearance\",\"mechanism\":\"Microglia upregulate MerTK receptor to recognize phosphatidylserine on OxPC-damaged cells, enabling engulfment and neutralization within phagosomes.\",\"target_gene\":\"MERTK\",\"confidence_score\":0.55,\"novelty_score\":0.5,\"feasibility_score\":0.6,\"impact_score\":0.65,\"composite_score\":0.57,\"testable_prediction\":\"MerTK conditional knockout mice will display impaired clearance of OxPC-positive debris and chronic inflammation in chronic EAE.\",\"skeptic_concern\":\"MerTK primarily recognizes phosphatidylserine, not oxidized phospholipids directly; OxPC may bind secondary bridging proteins whose identity is unknown.\"}],\"consensus_points\":[\"Microglia clearly mediate OxPC neutralization in MS lesions but the molecular mechanism remains mechanistically uncharacterized\",\"Both ApoE and TREM2 are upregulated in MS lesions and represent high-value therapeutic targets for MS neurodegeneration\",\"Phagocytic pathways are central to microglial function in this context, though receptor specificity for OxPCs is not established\"],\"dissent_points\":[\"THEORIST prioritizes ApoE-mediated lipid efflux as primary mechanism while EXPERT identifies TREM2-dependent phagocytosis as more tractable given active clinical trials\",\"The skeptic challenges whether any proposed mechanism can explain the directional transfer of OxPCs from neurons/oligodendrocytes to microglia\"],\"debate_summary\":\"The debate reveals that while microglia clearly neutralize toxic OxPCs in MS lesions, the primary receptor-mediated mechanism remains contested. TREM2-dependent phagocytosis emerges as the top-ranked hypothesis due to its high therapeutic tractability (active Phase 1/2 trials) and established role in recognizing lipid antigens, while ApoE-mediated sequestration offers strong expression data but faces a mechanistic gap regarding transcellular lipid export.\"}",
  "tokens_used": "834"
}